SlideShare une entreprise Scribd logo
1  sur  33
Télécharger pour lire hors ligne
Dopamine Transporter in
ADHD & Alcohol intake



                Motherisk Round
                    2011. 11. 29
                         B.Y. Lee
• Dopamine?
  - neurotransmitter?
  - reward system
  - related diseases

•   ADHD?
•   Alcohol? (pathway with dopamine)
•   ADHD- alcohol?
•   Dopamine – ADHD – alcohol?

• Related reports
   - epigenetic, dopaminergic, …
• Epigenetic project
• Vesicle release process:
   docking → priming → fusion

• Proteins involved in
   presynaptic exocytosis

• SNARE proteins: docking
   (membs close together before
    fusion)

• Synaptotagmin (vesicle protein)
   - Ca2+ sensor triggering fusion
I. Small molecule NT
   ① acetylcholine
   ② Amino Acids
     • glutamate
     • GABA & glycine
   ③ Biogenic amines
     • dopamine, norepinephrine (noradrenalin), epinephrine (adrenalin),
        serotonin (5-hydroxy tryptamine, 5-HT), histamine
   ④ Purines: ATP

II. Peptides
      • Substance P, CGRP(calcitonin gene related peptide), Enkephalin,
        Cholecystokinin(CCK), etc.
      • Opioid peptides
      • Substance P

III. Gaseous NT – Nitrous oxide, Carbon monoxide
1) Acetylcholine R
   ① Nicotinic: Ionotropic cys-loop superfamily
   ② Muscarinic: Metabotropic family R (M1~M5)
2) Inhibitory amino acid R: Ionotropic (GABAA,C & Gly), metabotropic (GABAB)
3) Excitatory amino acid R: Glutamate : NMDA, Kainate, AMPA
4) Purine (ATP) R: Ionotropic (P2X) & metabotropic (P2Y), presyn adenosine-R
5) Biogenic amine R: metabotropic except 5-HT3 (Ionotropic cys-loop superfamily)
6) Neuropeptides R: metabotropic R, diffused extracellular NT, more sensitive
7) Gas NT R: NO, CO - no binding to R, enzyme activation, modification of
   protein activity by nitrosylating
Synthesis  Storage and release  Receptor binding  Degradation


A. Release and degradation of the NT inside
    the axon terminal
B. Increased NT release into the synapse
C. Prevention of NT release into the synapse
D. Inhibition of synthesis of the NT
E. Reduced reuptake of the NT from the
    synapse
F. Reduced degradation of the NT in the
    synapse
G. Agonist (evoke same response as
    neurotransmitter) or antagonists (block
    response to neurotransmitter) can occupy
    the receptors
H. Reduced biochemical response inside the
    dendrite
Amine Compounds: Serotonin, Noradrenalin and Dopamine
These are the brain chemicals that to malfunction when stress levels become
more than a person can handle
Norepinephrine (NE)
• noradrenergic neurons in the locus ceruleus and nucleus subceruleus
• PNS: Smooth muscles, cardiac muscle and glands
    - Increase in blood pressure, constriction of arteries
• CNS: General behavior

Serotonin (5-HT)
• serotonergic neurons in the raphe nuclei
• Regulation of mood, behavior, appetite, and cerebral circulation.
• SSRIs (serotonin-specific reuptake inhibitors):
     – Inhibit reuptake and destruction of serotonin, prolonging the action of NT
     – Used as an antidepressant
     – Reduces appetite, treatment for anxiety, treatment for migraine headaches

Histamine
• Histaminergic neurons in tuberomammillary n. of hypothalamus Epinephrine
• Adrenergic neurons in rostral medulla

Epinephrine
• Adrenergic neurons in rostral medulla
Dopamine (DA) is a monoamine neurotransmitter that upon binding to
a dopamine receptor (G-protein coupled) releases a variety of downstream signals.

Where is dopamine formed/produced?
Mainly in areas of the central and peripheral nervous systems, such as in the
hypothalamus, the arcuate nucleus, and the caudad.

What are the functions of dopamine?
In the cardiovascular, renal, hormonal, and central nervous systems.

To control processes as diverse as
movement to drug addiction.

Dopamine dendrites extend into
various regions of the brain,
controlling different functions through
the stimulation of α and β adrenergic
and dopaminergic receptors (D1 and D2)
(Velasco et al., 1998).
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
DAT (The dopamine transporter)
regulates the uptake of dopamine
into neurons.
Dopamine is thought to bind to DT
via a separate binding domain that
is constructed of multiple amino
acid residues. These amino acid
residues are not present in the
primary structure of DT, but are
thought to have interactions with
the protein in its tertiary form.

MAO (monoamine oxidase)
breaks down free dopamine
(not contained in a vesicle).
MAO play a role in recycling the
components of dopamine, but it
also keeps the concentration of
dopamine lower than the rate at
which it is being produced.
• Dopaminergic neurons in the two main brainstem regions
  − substantia nigra pars compacta & ventral tegmental area (VTA)

 a. Nigrostriatal dopamine system:
    • Neurons in substantia nigra
      send fibers to corpus striatum.
    • Initiation of skeletal muscle movement.
    • Parkinson’s disease: degeneration
      of neurons in substantia nigra.

 b. Mesolimbic dopamine system:
   • Neurons originate in midbrain,
      send axons to limbic system.
   • Involved in behavior and reward.
   • Addictive drugs: promote activity
     in nucleus accumbens

 c. Meso-cortical pathway
    • negative symptoms (motivation and emotional response)

 d. Tubulo-infundibular pathway (endocrine related, prolactin)
• The mesolimbic dopamine path correspond to the parts of the limbic system,
  which are connected to emotions and is responsible for the ability to learn,
  the short-term memory, maintenance of moods and the alignment of
  thought and action.

• The mesolimbic system represents a modulation system, a filter and gating
  system for signals coming from the limbic system and for signals which
  maintain the basic functions of life and motivation (Koob 1992).

• The Nucleus accumbens,
   - the most important end point of the mesolimbic dopamine path.
   - a clearing centre for signals coming from the limbic system
   - the switching point, which anticipates the probability of reward-stimuli and
     steers the attention of the nerve system.
Mesolimbic Dopamine Pathway




            M-receptor
            D-receptor
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
• Dopamine deficiency in the striatum or substantia nigra :
  Parkinson’s-like symptoms.
  - movement becomes slow and rigid, accompanied by muscle tremor.
  - L-DOPA have been created to supplement the quantity of dopamine in the
    brain (Katzenschlager et al., 2002).

• An excessive amount of dopamine :
  Schizophrenia
  - characterized by altered behavior, and delusions.
  - Cocaine, block the return of dopamine into the brain,
    resulting in a build up of dopamine in the synapse,
    leading to drug-induced psychosis or schizophrenia.
  Tourett’s syndrome, ADHD
• The most commonly dignosed neuropsyciatric disorder in child hood

• ADHD wanes with age, symptoms can persist into adolescence and adulthood.

• The incidence in children : 3% ~ >5% (Biederman 1998)

• The diagnosis of ADHD : is currently based on DSM-IV criteria.

• The core symptoms : impulsivity, inattention, motor restlessness

• Heterogenous clinical symptoms, comorbidity (approx. 65%)
  with other disorders (conduct, mood, bipolar and anxiety disorders, Tourette’s)

• Abnormal morphology and function of ADHD brains, detected primarily by
  magnetic resonance imaging, converge on the catecholamine-rich frontal cortex
  and subcortical neural networks
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
• On the basis of the following lines of evidence, the DAT is one of several lead
  candidates for investigating the pathophysiology of ADHD and anti-ADHD drug
  mechanisms:

1) dopamine transport inhibitors indirectly activate dopamine receptor subtypes;
   D4 and D5 dopamine receptors are implicated in ADHD, and dopamine
   receptor activity enhances attention and experiential salience and engenders
   stimulation

2) the DAT is a selective and principal target of the most widely used
   antihyperactivity medications (amphetamine and methylphenidate)

3) the DAT gene is associated with ADHD

4) in some studies, abnormal levels of the DAT have been detected in brains of
   ADHD subjects.
• Dopamine is released from both dendrites and axons and might activate
  receptors locally or remotely through volume transmission.

• The DAT limits the duration of synaptic activity and diffusion by sequestering
  dopamine into neurons (Cragg and Rice 2004).

• The DAT is present on cell bodies, dendrites, and axons but apparently is not
  localized in the immediate active zone of the synapse (Hersch et al 1997)

• Accordingly, the DAT might reduce dopamine overflow into perisynaptic regions
  but not robustly sequester dopamine within the synapse.

• Overexpression of the DAT might lead to compensatory increases in dopamine
  release, a reduction in extracellular dopamine levels, or altered cellular
  distribution of the DAT.
Monoamine Neurotransmitter Transporters
Extracellular neurotransmitter concentrations are regulated, in part, by monoamine
transporters that sequester dopamine (DAT), serotonin (SERT), and norepinephrine
(NET) into neurons.

The majority of specific genes implicated in ADHD encode components of
catecholamine signaling systems.

The critical role of monoamine transporters for normal brain function is
underscored by the wide range of drugs that target monoamine transporters,
including medications for depression, ADHD, smoking addiction, obsessive-
compulsive disorder, and sleep disorders.




DAT is one of several
   genes implicated
               ADHD
•   DAT is a principal target of the most
    widely used antihyperactivity medications
    (amphetamine and methylphenidate).

•   All current anti-ADHD drugs modulate DA
    and NE levels in brain regions expressing
    DAT and NET. The majority of these drugs
    interfere with transporter-mediated
    clearance of extracellular neurotransmitters.

•   Interfere with DAT by brain-region- and
    drug-specific mechanisms  indirectly
    activating DA and possibly NE-R subtypes
     raising extracellular DA levels in DAT-
    rich brain regions  enhancing attention
    and experiential salience.

•   Repeated use of certain transport
    inhibitors (cocaine…), can eventually result
    in compulsive drug-seeking behavior.
• At the molecular level, the 12-membrane–spanning DAT protein contains a large
  extracellular loop, with consensus sites for glycosylation that function to
  regulate DAT trafficking and stability (Li et al 2004).
• Similarly, glycosylation of the NET controls stability, trafficking, and transport
  activity (Melikian et al 1996). Potential phosphorylation sites (serine, threonine,
  and tyrosine) might also acutely modulate DAT trafficking.
• A length or of sequence in the 3=-untranslated region of the DAT gene might
  affect DAT expression.
• A fixed length–repeat sequence, by number of repeats from 3 to 11.
   10 repeats sequences are the most common
• Inheritance of this repeat length in both alleles is associated with ADHD in some
  studies but accounts for less than 4% of the variance.
• Intragenic allelic interactions might distinguish haplotype functional diversity,
  and association studies might inadvertently group haplotypes of different
  function together on the basis of VNTR length.
                                                          The DAT Gene Variants
• DAT control of dopamine release is region specific.
   - In the striatum, dopamine clearance is a primary function of the DAT,
     whereas in the substantia nigra the DAT regulates extracellular dopamine
     levels by controlling both clearance and release.

• The complexity of region-specific DAT function is relevant to the pharmacologic
  effects of anti-ADHD drugs.

• Methylphenidate blocks dopamine transport, whereas amphetamine is a
  substrate for the DAT and presumably can trigger dopamine release
  in the substantia nigra.

 • These positron emission tomography
 (PET) scans show that patient with ADHD
 had lower levels of dopamine
 transporters in the nucleus accumbens ,
 a part of the brains reward center, than
 control subjects
Main Effects:
• Alcohol mainly acts on GABA
receptors (GABA receptors down
regulate the NT release of neurons,
essentially reducing neural activity) by
keeping its Cl- receptors open longer
than they normally would be.

• This causes GABA receptors to have
an increased effect and reduces
neural activity resulting in the calm,
sleepy feeling.

• Alcohol also inhibits glutamate
receptor function which causes
slurred speech, memory deficits, and
discoordintaion.
Secondary Effects:
• Raises the endorphin levels
  - causes the analgesic
    affect (pain killing).

• Increases the amount of
  dopamine in the brain –
  contributes to the addictive
  qualities.
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
• Can affect the methionine– homocysteine cycle by disrupting the enzymes
  required for methionine metabolism, thus interfering with SAM dependent
  methylation reactions.

• Alcohol and its breakdown products (i.e., metabolites such as acetaldehyde)
  also cause different site specific modifications in histones.

• Changes in the acetylation and methylation patterns of specific histones
  resulting from chronic alcohol feeding and high blood alcohol levels can lead
  to persistently altered gene expression and thus may play a role in this
  “epigenetic memory.”

• May reduce the absorption of folate, a key component of the methionine–
  homocysteine cycle, thereby influencing methylation capacity.
• During prenatal and early postnatal development, the epigenome is highly
  susceptible to environmental stimuli such as diet, drugs, environmental agents,
  and maternal behavior.

• Preconception, preimplantation, and gastrulation
  - Appear to be particularly sensitive to the teratogenic effects of alcohol,
  - The clinical variability of FASD may be related not only to the dose of alcohol
    but also to when alcohol exposure occurs in relation to developmental periods.

• Gastrulation appears to be most sensitive to teratogenic insults- a wide range
  of adverse effects (morphological and behavioral abnormalities)

• Both preconception and preimplantation alcohol exposure can cause adverse
  effects, even though the embryo is not directly exposed to alcohol at this stage
  because it is not yet implanted in the uterus and therefore not connected to or
  nourished by the maternal system, probably provides the most compelling
  evidence of a role for epigenetic mechanisms in the outcomes observed.
Maternal effect
  Paternal effect
                           (preconceptional/
(preconceptional)
                               prenatal)


            - How long ?
            - How severe ?
            - Epigenetic target ?
                - DAT ?
                - SERT ?
                - MecP2 ?
Thank you for your attention !

Contenu connexe

Tendances

Cardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychoticsCardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychoticsPawan Sharma
 
Dopamine hypothesis
Dopamine hypothesisDopamine hypothesis
Dopamine hypothesiskellula
 
The Neurobiology of Addiction
The Neurobiology of AddictionThe Neurobiology of Addiction
The Neurobiology of AddictionColleen Farrelly
 
Neurobiology of addiction
Neurobiology of addictionNeurobiology of addiction
Neurobiology of addictionVln Sekhar
 
Neurobiology of depression
Neurobiology of depressionNeurobiology of depression
Neurobiology of depressionSameeksha Das
 
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...Sawsan Aboul-Fotouh
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward systemAdonis Sfera, MD
 
role of neurotransmitters in neuropsychriatric diseases
role of neurotransmitters in neuropsychriatric diseases role of neurotransmitters in neuropsychriatric diseases
role of neurotransmitters in neuropsychriatric diseases Deepa Devkota
 
The Neurobiology of Depression (Dr Imran Waheed)
The Neurobiology of Depression (Dr Imran Waheed)The Neurobiology of Depression (Dr Imran Waheed)
The Neurobiology of Depression (Dr Imran Waheed)Imran Waheed
 
Brain stimulants
Brain stimulants Brain stimulants
Brain stimulants Amr Hassan
 
Current Management of Depression and Anxiety in Children and Adolescents
Current Management of Depression and Anxiety in Children and AdolescentsCurrent Management of Depression and Anxiety in Children and Adolescents
Current Management of Depression and Anxiety in Children and AdolescentsStephen Grcevich, MD
 
Hanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatryHanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatryHani Hamed
 
Introduction to Depressive Disorders in Children and Adolescents
Introduction to Depressive Disorders in Children and AdolescentsIntroduction to Depressive Disorders in Children and Adolescents
Introduction to Depressive Disorders in Children and AdolescentsStephen Grcevich, MD
 
Nicotine in psychiatry
Nicotine in psychiatryNicotine in psychiatry
Nicotine in psychiatryShehab Hassaan
 
Thyroid dysfunction psych aspects
Thyroid dysfunction psych aspects Thyroid dysfunction psych aspects
Thyroid dysfunction psych aspects Gibson Ponkalingal
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosisHIRENGEHLOTH
 
Genetic linkage in psychiatric disorders
Genetic linkage in psychiatric disordersGenetic linkage in psychiatric disorders
Genetic linkage in psychiatric disordersSujit Kumar Kar
 
Neurobiology and functional brain circuits in mood disorders
Neurobiology and functional brain circuits in mood disordersNeurobiology and functional brain circuits in mood disorders
Neurobiology and functional brain circuits in mood disordersSuman Sajan
 

Tendances (20)

Cardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychoticsCardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychotics
 
Dopamine hypothesis
Dopamine hypothesisDopamine hypothesis
Dopamine hypothesis
 
The Neurobiology of Addiction
The Neurobiology of AddictionThe Neurobiology of Addiction
The Neurobiology of Addiction
 
Huntington disease
Huntington diseaseHuntington disease
Huntington disease
 
Neurobiology of addiction
Neurobiology of addictionNeurobiology of addiction
Neurobiology of addiction
 
Neurobiology of depression
Neurobiology of depressionNeurobiology of depression
Neurobiology of depression
 
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
Pharmacotherapy of Drug Abuse or Addiction (Intoxication and Withdrawal Syndr...
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward system
 
role of neurotransmitters in neuropsychriatric diseases
role of neurotransmitters in neuropsychriatric diseases role of neurotransmitters in neuropsychriatric diseases
role of neurotransmitters in neuropsychriatric diseases
 
The Neurobiology of Depression (Dr Imran Waheed)
The Neurobiology of Depression (Dr Imran Waheed)The Neurobiology of Depression (Dr Imran Waheed)
The Neurobiology of Depression (Dr Imran Waheed)
 
Schizophrenia - Genetics
Schizophrenia - GeneticsSchizophrenia - Genetics
Schizophrenia - Genetics
 
Brain stimulants
Brain stimulants Brain stimulants
Brain stimulants
 
Current Management of Depression and Anxiety in Children and Adolescents
Current Management of Depression and Anxiety in Children and AdolescentsCurrent Management of Depression and Anxiety in Children and Adolescents
Current Management of Depression and Anxiety in Children and Adolescents
 
Hanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatryHanipsych, biomarkers in psychiatry
Hanipsych, biomarkers in psychiatry
 
Introduction to Depressive Disorders in Children and Adolescents
Introduction to Depressive Disorders in Children and AdolescentsIntroduction to Depressive Disorders in Children and Adolescents
Introduction to Depressive Disorders in Children and Adolescents
 
Nicotine in psychiatry
Nicotine in psychiatryNicotine in psychiatry
Nicotine in psychiatry
 
Thyroid dysfunction psych aspects
Thyroid dysfunction psych aspects Thyroid dysfunction psych aspects
Thyroid dysfunction psych aspects
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Genetic linkage in psychiatric disorders
Genetic linkage in psychiatric disordersGenetic linkage in psychiatric disorders
Genetic linkage in psychiatric disorders
 
Neurobiology and functional brain circuits in mood disorders
Neurobiology and functional brain circuits in mood disordersNeurobiology and functional brain circuits in mood disorders
Neurobiology and functional brain circuits in mood disorders
 

Similaire à 마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake

CNS introduction and antipsychotics.pptx
CNS introduction and antipsychotics.pptxCNS introduction and antipsychotics.pptx
CNS introduction and antipsychotics.pptxAmitSherawat2
 
Neurotransmitters- serotonin & dopamine by dr. rujul modi
Neurotransmitters- serotonin & dopamine by dr. rujul modiNeurotransmitters- serotonin & dopamine by dr. rujul modi
Neurotransmitters- serotonin & dopamine by dr. rujul modiRujul Modi
 
Neurotransmittter and role of dopamine in psychiatry
Neurotransmittter and role of dopamine in psychiatryNeurotransmittter and role of dopamine in psychiatry
Neurotransmittter and role of dopamine in psychiatryurvashi kumar
 
Monoamine Neurotransmitters-2.pptx
Monoamine Neurotransmitters-2.pptxMonoamine Neurotransmitters-2.pptx
Monoamine Neurotransmitters-2.pptxNimish Savaliya
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNSDekollu Suku
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemSONALPANDE5
 
3- Antipsychotic agents.ppt
3- Antipsychotic agents.ppt3- Antipsychotic agents.ppt
3- Antipsychotic agents.pptAshlynnElla3
 
Drugs acting on central nervous system introduction.pptx
Drugs acting on central nervous system introduction.pptxDrugs acting on central nervous system introduction.pptx
Drugs acting on central nervous system introduction.pptxsamrawitDemrew
 
PSY-2 Ch03: The Chemistry of Behavior
PSY-2 Ch03: The Chemistry of BehaviorPSY-2 Ch03: The Chemistry of Behavior
PSY-2 Ch03: The Chemistry of BehaviorLauraAdamsPhD
 
Neurotransmitters
NeurotransmittersNeurotransmitters
NeurotransmittersAnant Rathi
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons diseasemmurralii
 
1 Introduction to CNS pharmacology.ppt
1 Introduction to CNS pharmacology.ppt1 Introduction to CNS pharmacology.ppt
1 Introduction to CNS pharmacology.pptZeray4
 

Similaire à 마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake (20)

CNS introduction and antipsychotics.pptx
CNS introduction and antipsychotics.pptxCNS introduction and antipsychotics.pptx
CNS introduction and antipsychotics.pptx
 
Neurotransmitters- serotonin & dopamine by dr. rujul modi
Neurotransmitters- serotonin & dopamine by dr. rujul modiNeurotransmitters- serotonin & dopamine by dr. rujul modi
Neurotransmitters- serotonin & dopamine by dr. rujul modi
 
Neurotransmittter and role of dopamine in psychiatry
Neurotransmittter and role of dopamine in psychiatryNeurotransmittter and role of dopamine in psychiatry
Neurotransmittter and role of dopamine in psychiatry
 
Dopamine And Pathways
Dopamine And PathwaysDopamine And Pathways
Dopamine And Pathways
 
Monoamine Neurotransmitters-2.pptx
Monoamine Neurotransmitters-2.pptxMonoamine Neurotransmitters-2.pptx
Monoamine Neurotransmitters-2.pptx
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNS
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous system
 
Dopamine
DopamineDopamine
Dopamine
 
3- Antipsychotic agents.ppt
3- Antipsychotic agents.ppt3- Antipsychotic agents.ppt
3- Antipsychotic agents.ppt
 
CNS Disorders
CNS DisordersCNS Disorders
CNS Disorders
 
Drugs acting on central nervous system introduction.pptx
Drugs acting on central nervous system introduction.pptxDrugs acting on central nervous system introduction.pptx
Drugs acting on central nervous system introduction.pptx
 
PSY-2 Ch03: The Chemistry of Behavior
PSY-2 Ch03: The Chemistry of BehaviorPSY-2 Ch03: The Chemistry of Behavior
PSY-2 Ch03: The Chemistry of Behavior
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
neurotransmitters.pptx
neurotransmitters.pptxneurotransmitters.pptx
neurotransmitters.pptx
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
Neurotransmitter 2
Neurotransmitter 2Neurotransmitter 2
Neurotransmitter 2
 
NEUROTRANSMITTERS 1.pptx
NEUROTRANSMITTERS 1.pptxNEUROTRANSMITTERS 1.pptx
NEUROTRANSMITTERS 1.pptx
 
1 Introduction to CNS pharmacology.ppt
1 Introduction to CNS pharmacology.ppt1 Introduction to CNS pharmacology.ppt
1 Introduction to CNS pharmacology.ppt
 
CNS Pathways
CNS PathwaysCNS Pathways
CNS Pathways
 

Plus de mothersafe

장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주mothersafe
 
Safety of Mebendazole Use During Lactation
Safety of Mebendazole Use During LactationSafety of Mebendazole Use During Lactation
Safety of Mebendazole Use During Lactationmothersafe
 
Breastfeeding domeperiodne
Breastfeeding domeperiodneBreastfeeding domeperiodne
Breastfeeding domeperiodnemothersafe
 
(마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding (마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding mothersafe
 
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수mothersafe
 
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선mothersafe
 
Antiepileptics in pregnancy
Antiepileptics in pregnancyAntiepileptics in pregnancy
Antiepileptics in pregnancymothersafe
 
(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수mothersafe
 
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수mothersafe
 
(마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming (마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming mothersafe
 
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancymothersafe
 
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancymothersafe
 
Smoking in pregnancy
Smoking in pregnancySmoking in pregnancy
Smoking in pregnancymothersafe
 
(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancy(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancymothersafe
 
ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수mothersafe
 
2016 마더세이프 사업미팅
2016 마더세이프 사업미팅2016 마더세이프 사업미팅
2016 마더세이프 사업미팅mothersafe
 
임산부 영양상담
임산부 영양상담임산부 영양상담
임산부 영양상담mothersafe
 
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수mothersafe
 
(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식mothersafe
 
(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasd(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasdmothersafe
 

Plus de mothersafe (20)

장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
 
Safety of Mebendazole Use During Lactation
Safety of Mebendazole Use During LactationSafety of Mebendazole Use During Lactation
Safety of Mebendazole Use During Lactation
 
Breastfeeding domeperiodne
Breastfeeding domeperiodneBreastfeeding domeperiodne
Breastfeeding domeperiodne
 
(마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding (마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding
 
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
 
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
 
Antiepileptics in pregnancy
Antiepileptics in pregnancyAntiepileptics in pregnancy
Antiepileptics in pregnancy
 
(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수
 
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
 
(마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming (마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming
 
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
 
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
 
Smoking in pregnancy
Smoking in pregnancySmoking in pregnancy
Smoking in pregnancy
 
(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancy(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancy
 
ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수
 
2016 마더세이프 사업미팅
2016 마더세이프 사업미팅2016 마더세이프 사업미팅
2016 마더세이프 사업미팅
 
임산부 영양상담
임산부 영양상담임산부 영양상담
임산부 영양상담
 
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 
(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식
 
(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasd(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasd
 

Dernier

Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingAnonymous
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxkitati1
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisNilofarRasheed1
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?Ryan Addison
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 

Dernier (20)

Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_Wellbeing
 
Microbiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptxMicrobiology lecture presentation-1.pptx
Microbiology lecture presentation-1.pptx
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid Arthritis
 
Cone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptxCone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptx
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 

마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake

  • 1. Dopamine Transporter in ADHD & Alcohol intake Motherisk Round 2011. 11. 29 B.Y. Lee
  • 2. • Dopamine? - neurotransmitter? - reward system - related diseases • ADHD? • Alcohol? (pathway with dopamine) • ADHD- alcohol? • Dopamine – ADHD – alcohol? • Related reports - epigenetic, dopaminergic, … • Epigenetic project
  • 3. • Vesicle release process: docking → priming → fusion • Proteins involved in presynaptic exocytosis • SNARE proteins: docking (membs close together before fusion) • Synaptotagmin (vesicle protein) - Ca2+ sensor triggering fusion
  • 4. I. Small molecule NT ① acetylcholine ② Amino Acids • glutamate • GABA & glycine ③ Biogenic amines • dopamine, norepinephrine (noradrenalin), epinephrine (adrenalin), serotonin (5-hydroxy tryptamine, 5-HT), histamine ④ Purines: ATP II. Peptides • Substance P, CGRP(calcitonin gene related peptide), Enkephalin, Cholecystokinin(CCK), etc. • Opioid peptides • Substance P III. Gaseous NT – Nitrous oxide, Carbon monoxide
  • 5. 1) Acetylcholine R ① Nicotinic: Ionotropic cys-loop superfamily ② Muscarinic: Metabotropic family R (M1~M5) 2) Inhibitory amino acid R: Ionotropic (GABAA,C & Gly), metabotropic (GABAB) 3) Excitatory amino acid R: Glutamate : NMDA, Kainate, AMPA 4) Purine (ATP) R: Ionotropic (P2X) & metabotropic (P2Y), presyn adenosine-R 5) Biogenic amine R: metabotropic except 5-HT3 (Ionotropic cys-loop superfamily) 6) Neuropeptides R: metabotropic R, diffused extracellular NT, more sensitive 7) Gas NT R: NO, CO - no binding to R, enzyme activation, modification of protein activity by nitrosylating
  • 6. Synthesis  Storage and release  Receptor binding  Degradation A. Release and degradation of the NT inside the axon terminal B. Increased NT release into the synapse C. Prevention of NT release into the synapse D. Inhibition of synthesis of the NT E. Reduced reuptake of the NT from the synapse F. Reduced degradation of the NT in the synapse G. Agonist (evoke same response as neurotransmitter) or antagonists (block response to neurotransmitter) can occupy the receptors H. Reduced biochemical response inside the dendrite
  • 7. Amine Compounds: Serotonin, Noradrenalin and Dopamine These are the brain chemicals that to malfunction when stress levels become more than a person can handle
  • 8. Norepinephrine (NE) • noradrenergic neurons in the locus ceruleus and nucleus subceruleus • PNS: Smooth muscles, cardiac muscle and glands - Increase in blood pressure, constriction of arteries • CNS: General behavior Serotonin (5-HT) • serotonergic neurons in the raphe nuclei • Regulation of mood, behavior, appetite, and cerebral circulation. • SSRIs (serotonin-specific reuptake inhibitors): – Inhibit reuptake and destruction of serotonin, prolonging the action of NT – Used as an antidepressant – Reduces appetite, treatment for anxiety, treatment for migraine headaches Histamine • Histaminergic neurons in tuberomammillary n. of hypothalamus Epinephrine • Adrenergic neurons in rostral medulla Epinephrine • Adrenergic neurons in rostral medulla
  • 9. Dopamine (DA) is a monoamine neurotransmitter that upon binding to a dopamine receptor (G-protein coupled) releases a variety of downstream signals. Where is dopamine formed/produced? Mainly in areas of the central and peripheral nervous systems, such as in the hypothalamus, the arcuate nucleus, and the caudad. What are the functions of dopamine? In the cardiovascular, renal, hormonal, and central nervous systems. To control processes as diverse as movement to drug addiction. Dopamine dendrites extend into various regions of the brain, controlling different functions through the stimulation of α and β adrenergic and dopaminergic receptors (D1 and D2) (Velasco et al., 1998).
  • 11. DAT (The dopamine transporter) regulates the uptake of dopamine into neurons. Dopamine is thought to bind to DT via a separate binding domain that is constructed of multiple amino acid residues. These amino acid residues are not present in the primary structure of DT, but are thought to have interactions with the protein in its tertiary form. MAO (monoamine oxidase) breaks down free dopamine (not contained in a vesicle). MAO play a role in recycling the components of dopamine, but it also keeps the concentration of dopamine lower than the rate at which it is being produced.
  • 12. • Dopaminergic neurons in the two main brainstem regions − substantia nigra pars compacta & ventral tegmental area (VTA) a. Nigrostriatal dopamine system: • Neurons in substantia nigra send fibers to corpus striatum. • Initiation of skeletal muscle movement. • Parkinson’s disease: degeneration of neurons in substantia nigra. b. Mesolimbic dopamine system: • Neurons originate in midbrain, send axons to limbic system. • Involved in behavior and reward. • Addictive drugs: promote activity in nucleus accumbens c. Meso-cortical pathway • negative symptoms (motivation and emotional response) d. Tubulo-infundibular pathway (endocrine related, prolactin)
  • 13. • The mesolimbic dopamine path correspond to the parts of the limbic system, which are connected to emotions and is responsible for the ability to learn, the short-term memory, maintenance of moods and the alignment of thought and action. • The mesolimbic system represents a modulation system, a filter and gating system for signals coming from the limbic system and for signals which maintain the basic functions of life and motivation (Koob 1992). • The Nucleus accumbens, - the most important end point of the mesolimbic dopamine path. - a clearing centre for signals coming from the limbic system - the switching point, which anticipates the probability of reward-stimuli and steers the attention of the nerve system.
  • 14. Mesolimbic Dopamine Pathway M-receptor D-receptor
  • 16. • Dopamine deficiency in the striatum or substantia nigra : Parkinson’s-like symptoms. - movement becomes slow and rigid, accompanied by muscle tremor. - L-DOPA have been created to supplement the quantity of dopamine in the brain (Katzenschlager et al., 2002). • An excessive amount of dopamine : Schizophrenia - characterized by altered behavior, and delusions. - Cocaine, block the return of dopamine into the brain, resulting in a build up of dopamine in the synapse, leading to drug-induced psychosis or schizophrenia. Tourett’s syndrome, ADHD
  • 17. • The most commonly dignosed neuropsyciatric disorder in child hood • ADHD wanes with age, symptoms can persist into adolescence and adulthood. • The incidence in children : 3% ~ >5% (Biederman 1998) • The diagnosis of ADHD : is currently based on DSM-IV criteria. • The core symptoms : impulsivity, inattention, motor restlessness • Heterogenous clinical symptoms, comorbidity (approx. 65%) with other disorders (conduct, mood, bipolar and anxiety disorders, Tourette’s) • Abnormal morphology and function of ADHD brains, detected primarily by magnetic resonance imaging, converge on the catecholamine-rich frontal cortex and subcortical neural networks
  • 19. • On the basis of the following lines of evidence, the DAT is one of several lead candidates for investigating the pathophysiology of ADHD and anti-ADHD drug mechanisms: 1) dopamine transport inhibitors indirectly activate dopamine receptor subtypes; D4 and D5 dopamine receptors are implicated in ADHD, and dopamine receptor activity enhances attention and experiential salience and engenders stimulation 2) the DAT is a selective and principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate) 3) the DAT gene is associated with ADHD 4) in some studies, abnormal levels of the DAT have been detected in brains of ADHD subjects.
  • 20. • Dopamine is released from both dendrites and axons and might activate receptors locally or remotely through volume transmission. • The DAT limits the duration of synaptic activity and diffusion by sequestering dopamine into neurons (Cragg and Rice 2004). • The DAT is present on cell bodies, dendrites, and axons but apparently is not localized in the immediate active zone of the synapse (Hersch et al 1997) • Accordingly, the DAT might reduce dopamine overflow into perisynaptic regions but not robustly sequester dopamine within the synapse. • Overexpression of the DAT might lead to compensatory increases in dopamine release, a reduction in extracellular dopamine levels, or altered cellular distribution of the DAT.
  • 21. Monoamine Neurotransmitter Transporters Extracellular neurotransmitter concentrations are regulated, in part, by monoamine transporters that sequester dopamine (DAT), serotonin (SERT), and norepinephrine (NET) into neurons. The majority of specific genes implicated in ADHD encode components of catecholamine signaling systems. The critical role of monoamine transporters for normal brain function is underscored by the wide range of drugs that target monoamine transporters, including medications for depression, ADHD, smoking addiction, obsessive- compulsive disorder, and sleep disorders. DAT is one of several genes implicated ADHD
  • 22. DAT is a principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate). • All current anti-ADHD drugs modulate DA and NE levels in brain regions expressing DAT and NET. The majority of these drugs interfere with transporter-mediated clearance of extracellular neurotransmitters. • Interfere with DAT by brain-region- and drug-specific mechanisms  indirectly activating DA and possibly NE-R subtypes  raising extracellular DA levels in DAT- rich brain regions  enhancing attention and experiential salience. • Repeated use of certain transport inhibitors (cocaine…), can eventually result in compulsive drug-seeking behavior.
  • 23. • At the molecular level, the 12-membrane–spanning DAT protein contains a large extracellular loop, with consensus sites for glycosylation that function to regulate DAT trafficking and stability (Li et al 2004). • Similarly, glycosylation of the NET controls stability, trafficking, and transport activity (Melikian et al 1996). Potential phosphorylation sites (serine, threonine, and tyrosine) might also acutely modulate DAT trafficking.
  • 24. • A length or of sequence in the 3=-untranslated region of the DAT gene might affect DAT expression. • A fixed length–repeat sequence, by number of repeats from 3 to 11. 10 repeats sequences are the most common • Inheritance of this repeat length in both alleles is associated with ADHD in some studies but accounts for less than 4% of the variance. • Intragenic allelic interactions might distinguish haplotype functional diversity, and association studies might inadvertently group haplotypes of different function together on the basis of VNTR length. The DAT Gene Variants
  • 25. • DAT control of dopamine release is region specific. - In the striatum, dopamine clearance is a primary function of the DAT, whereas in the substantia nigra the DAT regulates extracellular dopamine levels by controlling both clearance and release. • The complexity of region-specific DAT function is relevant to the pharmacologic effects of anti-ADHD drugs. • Methylphenidate blocks dopamine transport, whereas amphetamine is a substrate for the DAT and presumably can trigger dopamine release in the substantia nigra. • These positron emission tomography (PET) scans show that patient with ADHD had lower levels of dopamine transporters in the nucleus accumbens , a part of the brains reward center, than control subjects
  • 26. Main Effects: • Alcohol mainly acts on GABA receptors (GABA receptors down regulate the NT release of neurons, essentially reducing neural activity) by keeping its Cl- receptors open longer than they normally would be. • This causes GABA receptors to have an increased effect and reduces neural activity resulting in the calm, sleepy feeling. • Alcohol also inhibits glutamate receptor function which causes slurred speech, memory deficits, and discoordintaion.
  • 27. Secondary Effects: • Raises the endorphin levels - causes the analgesic affect (pain killing). • Increases the amount of dopamine in the brain – contributes to the addictive qualities.
  • 30. • Can affect the methionine– homocysteine cycle by disrupting the enzymes required for methionine metabolism, thus interfering with SAM dependent methylation reactions. • Alcohol and its breakdown products (i.e., metabolites such as acetaldehyde) also cause different site specific modifications in histones. • Changes in the acetylation and methylation patterns of specific histones resulting from chronic alcohol feeding and high blood alcohol levels can lead to persistently altered gene expression and thus may play a role in this “epigenetic memory.” • May reduce the absorption of folate, a key component of the methionine– homocysteine cycle, thereby influencing methylation capacity.
  • 31. • During prenatal and early postnatal development, the epigenome is highly susceptible to environmental stimuli such as diet, drugs, environmental agents, and maternal behavior. • Preconception, preimplantation, and gastrulation - Appear to be particularly sensitive to the teratogenic effects of alcohol, - The clinical variability of FASD may be related not only to the dose of alcohol but also to when alcohol exposure occurs in relation to developmental periods. • Gastrulation appears to be most sensitive to teratogenic insults- a wide range of adverse effects (morphological and behavioral abnormalities) • Both preconception and preimplantation alcohol exposure can cause adverse effects, even though the embryo is not directly exposed to alcohol at this stage because it is not yet implanted in the uterus and therefore not connected to or nourished by the maternal system, probably provides the most compelling evidence of a role for epigenetic mechanisms in the outcomes observed.
  • 32. Maternal effect Paternal effect (preconceptional/ (preconceptional) prenatal) - How long ? - How severe ? - Epigenetic target ? - DAT ? - SERT ? - MecP2 ?
  • 33. Thank you for your attention !